Physician profile
William M Figlesthaler
NPI 1255379277
$872.43
in general payments reported to CMS, 2019-2025
14 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $54.40 · 2021: $262 · 2022: $13.97 · 2023: $21.65 · 2024: $136 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $209.84 | 2019-2021 | |
| Boston Scientific Corporation | $146.42 | 2020-2025 | Spaceoar Vue System - 10ml, Ams 700 |
| Janssen Scientific Affairs, LLC | $133.51 | 2025 | Akeega, Balversa, Erleada |
| Allergan, INC. | $96.30 | 2019-2021 | |
| Laborie Medical Technologies Corp. | $60.09 | 2024-2025 | Eclipse, Optilume Bph Drug Coated Balloon Catheter, Urgent Pc Neuromodulation System |
| Ambu INC. | $45.53 | 2021 | |
| Abbvie INC. | $35.62 | 2022-2023 | |
| Coloplast Corp | $30.02 | 2019-2021 | |
| Bioprotect Medical, INC. | $26.55 | 2025 | Bioprotect Balloon Implant System |
| Therapeuticsmd, INC. | $20.71 | 2019 | |
| Healthtronics Stone Solutions, LLC | $18.75 | 2021 | |
| Axonics, INC. | $17.14 | 2021 | |
| Sumitomo Pharma America, INC. | $16.99 | 2024 | Gemtesa |
| Olympus America INC. | $14.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Figlesthaler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.